Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04147533 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia

Study acronym: HALF
StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 26, 2024 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study Identification, Study Statusv8
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary and study completion dates: Dec 2025 to Jun 2026
    • Site details revised at 8 of 8 sites
    v7
  3. Primary and study completion dates: Dec 2024 to Dec 2025v6
  4. Site details revised at 4 of 8 sitesv5
  5. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Feb 2024 to Dec 2024
    • Start date changed from estimate of Jul 2020 to Jun 16, 2020
    • Site details revised at 8 of 8 sites
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Mar 2020 to Jul 2020v3
  2. Start date: Nov 2019 to Mar 2020
    • Primary completion date: Oct 2023 to Feb 2024
    • Study completion date: Oct 2024 to Dec 2024
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluation of the efficacy and safety of withdrawal of tyrosine kinase inhibitors after previous two-step dose reduction in patients with chronic myeloid leukemia in deep molecular remission
Trial Details
NCT Number NCT04147533
Lead Sponsor Masaryk University
Conditions
(from sponsor)		 Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug
Related terms Leukemia, Myeloid, Chronic-Phase, Substance Withdrawal Syndrome
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov